BIPM (2006). Bureau International des Poids et Mesures. The International System of Units 91 (SI). (Bureau International des Poids et Mesures, Pavillon de Breteuil, Sèvres Cedex, France).
2.
BlakelyE.A., TobiasC.A., YangT.C., SmithK.C., and LymanJ.T. (1979). ‘Inactivation of human kidney cells by high-energy monoenergetic heavy-ion beams,’ Radiat. Res.80, 122–160.
3.
ChenG.T., SinghR.P., CastroJ.R., LymanJ.T., and QuiveyJ.M. (1979). ‘Treatment planning for heavy ion radiotherapy,’ Int. J. Radiat. Oncol. Biol. Phys.5, 1809–1819.
4.
ElsässerT., and ScholzM. (2007). ‘Cluster effects within the local effect model,’ Radiat. Res.167, 319–329.
5.
ElsässerT., KramerM., and ScholzM. (2008). ‘Accuracy of the local effect model for the prediction of biologic effects of carbon ion beams in vitro and in vivo,’ Int. J. Radiat. Oncol. Biol. Phys.71, 866–872.
6.
ElsässerT., WeyratherW.K., FriedrichT., DuranteM., IancuG., KramerM., KraglG., BronsS., WinterM., WeberK.J., and ScholzM. (2010). ‘Quantification of the relative biological effectiveness for ion beam radiotherapy: direct experimental comparison of proton and carbon ion beams and a novel approach for treatment planning,’ Int. J. Radiat. Oncol. Biol. Phys.78, 1177–1183.
7.
FossatiP., MolinelliS., MatsufujiN., CioccaM., MirandolaA., MairaniA., MizoeJ., HasegawaA., ImaiR., KamadaT., OrecchiaR., and TsujiiH. (2012). ‘Dose prescription in carbon ion radiotherapy: a planning study to compare NIRS and LEM approaches with a clinically-oriented strategy,’ Phys. Med. Biol.57, 7543–7554.
8.
FurusawaY., FukutsuK., AokiM., ItsukaichiH., Eguchi-KasaiK., OharaH., YatagaiF., KanaiT., and AndoK. (2000). ‘Inactivation of aerobic and hypoxic cells from three different cell lines by accelerated 3He-, 12C-and 20Ne-ion beams,’ Radiat. Res.154, 485–496.
9.
GlowaC., KargerC.P., BronsS., ZhaoD., MasonR.P., HuberP.E., DebusJ., and PeschkeP. (2016). ‘Carbon ion radiotherapy decreases the impact of tumor heterogeneity on radiation response in experimental prostate tumors,’ Cancer Lett.378, 97–103.
10.
GrünR., FriedrichT., KramerM., ZinkK., DuranteM., Engenhart-CabillicR., and ScholzM. (2015). ‘Assessment of potential advantages of relevant ions for particle therapy: a model based study,’ Med. Phys.42, 1037–1047.
11.
HawkinsR.B. (1996). ‘A microdosimetric-kinetic model of cell death from exposure to ionizing radiation of any LET, with experimental and clinical applications,’ Int. J. Radiat. Biol.69, 739–755.
12.
HendersonF.C., McCoolK., SeigleJ., JeanW., HarterW., and GagnonG.J. (2009). ‘Treatment of Chordomas with Cyberknife: Georgetown University Experience and Treatment Recommendations,’ Neurosurgery64, A44–A53.
13.
HornseyS. (1991). ‘Experimental central nervous system injury from fast neutrons,’ in Radiation Injury to the Nervous System, GutinP.H., LeibelS.A., and SnelineG.E., Eds. (Raven Press, New York, NY).
14.
ICRU (1970). International Commission on Radiation Units and Measurements. Linear Energy Transfer. ICRU Report 16 (International Commission on Radiation Units and Measurements, Bethesda, MD).
15.
ICRU (1993a). International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy. ICRU Report 50 (International Commission on Radiation Units and Measurements, Bethesda, MD).
16.
ICRU (1993b). International Commission on Radiation Units and Measurements. Stopping Powers and Ranges for Protons and Alpha Particles. ICRU Report 49 (International Commission on Radiation Units and Measurements, Bethesda, MD).
17.
ICRU (1998). International Commission on Radiation Units and Measurements. Clinical Proton Dosimetry Part I: Beam Production, Beam Delivery and Measurement of Absorbed Dose. ICRU Report 59 (International Commission on Radiation Units and Measurements, Bethesda, MD).
18.
ICRU (1999). International Commission on Radiation Units and Measurements. Prescribing, Recording and Reporting Photon Beam Therapy (Supplement to ICRU Report 50). ICRU Report 62 (International Commission on Radiation Units and Measurements, Bethesda, MD).
19.
ICRU (2004). International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Electron Beam Therapy. ICRU Report 71, J. ICRU Vol. 4(1) (Oxford University Press, Oxford).
20.
ICRU (2007). International Commission on Radiation Units and Measurements. Prescribing, Recording, and Reporting Proton-Beam Therapy. ICRU Report 78, J. ICRU Vol. 7(2) (Oxford University Press, Oxford).
21.
InaniwaT., FurukawaT., KaseY., MatsufujiN., ToshitoT., MatsumotoY., FurusawaY., and NodaK. (2010). ‘Treatment planning for a scanned carbon beam with a modified microdosimetric kinetic model,’ Phys. Med. Biol.55, 6721–6737.
22.
InaniwaT., KanematsuN., MatsufujiN., KanaiT., ShiraiT., NodaK., TsujiH., KamadaT., and TsujiiH. (2015). ‘Reformulation of a clinical-dose system for carbon-ion radiotherapy treatment planning at the National Institute of Radiological Sciences, Japan,’ Phys. Med. Biol.60, 3271–3286.
23.
KanaiT., FurusawaY., FukutsuK., ItsukaichiH., Eguchi-KasaiK., and OharaH. (1997). ‘Irradiation of mixed beam and design of spread-out Bragg peak for heavy-ion radiotherapy,’ Radiat. Res.147, 78–85.
24.
KanaiT., EndoM., MinoharaS., MiyaharaN., Koyama-itoH., TomuraH., MatsufujiN., FutamiY., FukumuraA., HiraokaT., FurusawaY., AndoK., SuzukiM., SogaF., and KawachiK. (1999). ‘Biophysical characteristics of HIMAC clinical irradiation system for heavy-ion radiation therapy,’ Int. J. Radiat. Oncol. Biol. Phys.44, 201–210.
25.
KargerC.P., PeschkeP., Sanchez-BrandelikR., ScholzM., and DebusJ. (2006). ‘Radiation tolerance of the rat spinal cord after 6 and 18 fractions of photons and carbon ions: experimental results and clinical implications,’ Int. J. Radiat. Oncol. Biol. Phys.66, 1488–1497.
26.
KargerC.P., PeschkeP., ScholzM., HuberP.E., and DebusJ. (2013). ‘Relative biological effectiveness of carbon ions in a rat prostate carcinoma in vivo: comparison of 1, 2, and 6 fractions,’ Int. J. Radiat. Oncol. Biol. Phys.86, 450–455.
27.
KaseY., KanaiT., MatsumotoY., FurusawaY., OkamotoH., AsabaT., SakamaM., and ShinodaH. (2006). ‘Microdosimetric measurements and estimation of human cell survival for heavy-ion beams,’ Radiat. Res.166, 629–638.
28.
KaseY., KanaiT., MatsufujiN., FurusawaY., ElsässerT., and ScholzM. (2007). ‘Biophysical calculation of cell survival probabilities using amorphous track structure models for heavy-ion irradiation,’ Phys. Med. Biol.53, 37.
29.
KatzR., AckersonB., HomayoonfarM., and SharmaS.C. (1971). ‘Inactivation of cells by heavy ion bombardment,’ Radiat. Res.47, 402–425.
30.
KrämerM., and ScholzM. (2000). ‘Treatment planning for heavy-ion radiotherapy: calculation and optimization of biologically effective dose,’ Phys. Med. Biol.45, 3319–3330.
31.
KrämerM., and ScholzM. (2006). ‘Rapid calculation of biological effects in ion radiotherapy,’ Phys. Med. Biol.51, 1959–1970.
32.
KrämerM., JäkelO., HabererT., KraftG., SchardtD., and WeberU. (2000). ‘Treatment planning for heavy-ion radiotherapy: physical beam model and dose optimization,’ Phys. Med. Biol.45, 3299–3317.
33.
LymanJ.T., and HowardJ. (1977). ‘Dosimetry and instrumentation for helium and heavy ions,’ Int. J. Radiat. Oncol. Biol. Phys.3, 81–85.
34.
LymanJ.T., and WolbarstA.B. (1987). ‘Optimization of radiation therapy, III: A method of assessing complication probabilities from dose-volume histograms,’ Int. J. Radiat. Oncol. Biol. Phys.13, 103–109.
35.
LymanJ.T., HowardJ., KansteinL., and AlonsoJ.R. (1980). Radiological Physics of Heavy Charged-Particle Beams Used for Therapy. (report unpublished).
36.
MairaniA., BronsS., CeruttiF., FassoA., FerrariA., KramerM., ParodiK., ScholzM., and SommererF. (2010). ‘The FLUKA Monte Carlo code coupled with the local effect model for biological calculations in carbon ion therapy,’ Phys. Med. Biol.55, 4273–4289.
37.
MolinelliS., MagroG., MairaniA., MatsufujiN., KanematsuN., InaniwaT., MirandolaA., RussoS., MastellaE., HasegawaA., TsujiH., YamadaS., VischioniB., VitoloV., FerrariA., CioccaM., KamadaT., TsujiiH., OrecchiaR., and FossatiP. (2016). ‘Dose prescription in carbon ion radiotherapy: how to compare two different RBE-weighted dose calculation systems,’ Radiother. Oncol.120, 307–312.
38.
PettiP.L., LymanJ.T., RennerT.R., CastroJ.R., CollierJ.M., DaftariI.K., and LudewigtB.A. (1991a). ‘Design of beam-modulating devices for charged-particle therapy,’ Med. Phys.18, 513–518.
39.
PettiP.L., LymanJ.T., and CastroJ.R. (1991b). ‘Sensitivity of helium beam-modulator design to uncertainties in biological data,’ Med. Phys.18, 506–512.
40.
SaagerM., GlowaC., PeschkeP., BronsS., GrunR., ScholzM., HuberP.E., DebusJ., and KargerC.P. (2016). ‘The relative biological effectiveness of carbon ion irradiations of the rat spinal cord increases linearly with LET up to 99 keV/mum,’ Acta Oncol.55, 1512–1515.
41.
SatoT., KaseY., WatanabeR., NiitaK., and SihverL. (2009). ‘Biological dose estimation for charged-particle therapy using an improved PHITS code coupled with a microdosimetric kinetic model,’ Radiat. Res.171, 107–117.
42.
ScholzM., and KraftG. (1996). ‘Track structure and the calculation of biological effects of heavy charged particles,’ Adv. Space Res.18, 5–14.
43.
ScholzM., KellererA.M., Kraft-WeyratherW., and KraftG. (1997). ‘Computation of cell survival in heavy ion beams for therapy. The model and its approximation,’ Radiat. Environ. Biophys.36, 59–66.
44.
SteinsträterO., GrunR., ScholzU., FriedrichT., DuranteM., and ScholzM. (2012). ‘Mapping of RBE-weighted doses between HIMAC- and LEM-Based treatment planning systems for carbon ion therapy,’ Int. J. Radiat. Oncol. Biol. Phys.84, 854–860.
45.
SuzukiM., KaseY., YamaguchiH., KanaiT., and AndoK. (2000). ‘Relative biological effectiveness for cell-killing effect on various human cell lines irradiated with heavy-ion medical accelerator in CHIBA (HIMAC) carbon-ion beams,’ Int. J. Radiat. Oncol.48, 241–250.
46.
TsunemotoH., AraiT., MoritaS., IshikawaT., AokiY., TakadaN., and KamataS. (1982). ‘Japanese experience with clinical trials of fast neutrons,’ Int. J. Radiat. Oncol. Biol. Phys.8, 2169–2172.
47.
UzawaA., AndoK., FurusawaY., KagiyaG., FujiH., HataM., SakaeT., TerunumaT., ScholzM., RitterS., and PeschkeP. (2007). ‘Biological intercomparison using gut crypt survivals for proton and carbon-ion beams,’ J. Radiat. Res. (Tokyo)48, A75–A80.
48.
UzawaA., AndoK., KoikeS., FurusawaY., MatsumotoY., TakaiN., HirayamaR., WatanabeM., ScholzM., ElsässerT., and PeschkeP. (2009). ‘Comparison of biological effectiveness of carbon-ion beams in Japan and Germany,’ Int. J. Radiat. Oncol. Biol. Phys.73, 1545–1551.
49.
WenzlT., and WilkensJ.J. (2011). ‘Modelling of the oxygen enhancement ratio for ion beam radiation therapy,’ Phys. Med. Biol.56, 3251–3268.
50.
WoodruffK.H., CastroJ.R., QuiveyJ.M., SaundersW.M., ChenG.T., LymanJ.T., PitluckS., TobiasC.A., WaltonR.E., and PetersT.C. (1984). ‘Postmortem examination of 22 pancreatic carcinoma patients treated with helium ion irradiation,’ Cancer53, 420–425.
51.
ZaiderM., and RossiH.H. (1980). ‘The synergistic effects of different radiations,’ Radiat. Res.83, 732–739.
52.
ZinkS.R., LymanJ.T., CastroJ.R., ChenG.T., CollierJ.M., and SaundersW.M. (1988). ‘Treatment planning study for carcinoma of the esophagus: helium ions versus photons,’ Int. J. Radiat. Oncol. Biol. Phys.14, 993–1000.